Drug Safety Fears May Limit Reimporting and Shape R&D

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-02-02-2005
Volume 29
Issue 2

Concerns about risky medicines may reduce pressure to expand drug imports while boosting demand for more comparative analyses of therapies.

External Link - article-146233.pdf

Articles in this issue
Correcting the Course
Using Extrusion-Spheronization to Develop Controlled-Release Formulations of Azithromycin
Toward a Generic Approach for Stress Testing of Drug Substances and Drug Products
February 2005
Good Work and True: USP Prepares for Convention 2005
Contract Manufacturers Getting Squeezed
In the Spotlight-February 2005
Emerging Analytical Technology: Moving from the Lab to the Line
Drug Safety Fears May Limit Reimporting and Shape R&D
In Defense of USP Singlet Testing
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | Image Credit: © Tada Images - stock.adobe.com

FDA Posts Slate of Seven Warning Letters Following Company Inspections

Patrick Lavery
June 12th 2025
Article

The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. | Image source: ©huiying - stock.adobe.com

ICH Q6B for Analytics

Richard Easton;Christopher Ziegenfuss
June 6th 2025
Article

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Landkarte *** Europa | Image credit: ©beugdesign - Stock.adobe.com

EMA Is Tackling Vulnerabilities in the Supply Chain of Radiopharmaceuticals

Cheryl Barton
June 4th 2025
Article

EMA has published recommendations to address potential radiopharmaceutical shortages.

Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com

Guidance on Quality Culture Standards

Matt Cushing;Susan J. Schniepp
June 3rd 2025
Article

Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.